"ID","FLDNAME","TBLNAME","CRFNAME","QUESTION","TEXT","STATUS","DEPRULE","TYPE","LENGTH","DECIML","RANGEVAL","RANGESQL","RANGEPRL","UNITS","CODE","NOTES","OBJID","COLID","RANGEJSCPT","NAVJSCPT","FTYPE","TAB","DE","MC","VISIBLE","LOGVISIBLE","MTBLNAME","SUBTBLNAME","POPJSCPT","GRID","DEF","update_stamp"
"","RID","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","Participant roster ID","-4","-4","-4","-4","","-4","-4","-4","-4","-4","The 4 digit roster ID (RID) should be used to merge data","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","BATCH.ID","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","-4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PDI.ID","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","-4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","C13.PE.P.16.0.22.6","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","13C Labeled PlsEtn 16:0/22:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","C13.PE.16.0.22.6","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","13C Labeled PtdEtn 16:0/22:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.16.0.18.3","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 16:0/18:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.16.0.22.6","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 16:0/22:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.18.0.20.5","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 18:0/20:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.18.0.22.4","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 18:0/22:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.16.0.18.2","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 16:0/18:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.18.0.20.5","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 18:0/20:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.16.0.22.4","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 16:0/22:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.16.0.22.6","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 16:0/22:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","SAMPLE.TYPE","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","-4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.16.0.18.0","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 16:0/18:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.16.0.18.1","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 16:0/18:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.16.0.18.2","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 16:0/18:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.16.0.20.4","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 16:0/20:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.16.0.22.4","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 16:0/22:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.16.0.24.6","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 16:0/24:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.18.0.18.1","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 18:0/18:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.18.0.18.2","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 18:0/18:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.18.0.18.3","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 18:0/18:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.18.0.20.4","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 18:0/20:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.18.0.22.6","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 18:0/22:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.18.0.24.6","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 18:0/24:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.16.0.18.0","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 16:0/18:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.16.0.18.1","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 16:0/18:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.16.0.18.3","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 16:0/18:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.16.0.20.4","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 16:0/20:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.18.0.18.0","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 18:0/18:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.18.0.18.1","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 18:0/18:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.18.0.18.2","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 18:0/18:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.18.0.18.3","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 18:0/18:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.18.0.22.4","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 18:0/22:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.18.0.22.6","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 18:0/22:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.16.0.20.5","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PtdEtn 16:0/20:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.16.0.20.5","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 16:0/20:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","PE.P.18.0.20.4","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","PlsEtn 18:0/20:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"
"","COMMENTS","ADMCPDIPEPEAKHEIGHTS","AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios","-4","-4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2017-08-10 09:20:58.0"